|
 |
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS |
 |
| |
|
|
| In her Editor's Letter, Dr Patricia Lobo provides a brief summary of the articles in this issue of PMPS |
|
|
|
| Derek Woodcock, Technical Services Director for Britannia Pharmaceuticals Ltd., looks at the wider roles of pulmonary surfactant, in Surfactant - Therapy, Excipient and Humectant |
|
|
|
| In Providing Global Access to Medicines - The Role of Manufacture and Supply, David Webber, Fellow and Director of Economic Policy at the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), advocates the removal of barriers and impediments that disadvantage companies in their pursuit of low-cost manufacturing |
|
|
| The global manufacture and distribution of counterfeit products is a growing concern. Timothy Trainer, President of the International AntiCounterfeiting Coalition, Inc., discusses the dangers the industry faces, in Counterfeiting - A Multi-Industry and a Consumer Threat |
|
|
| In Counterfeit Drugs - A Clear and Present Danger, Dr James Rittenburg, Vice President of Technology and Business Development at Biocode, looks at why the design and implementation of pre-emptive brand protection strategies should be viewed as an integral part of the drug development process |
|
|
| Wolfgang Winter, Senior Product Manager of Data Systems at Agilent Technologies GmbH, investigates the role of computer-based regression for computer system validation, in Automated Regression Testing for Computer System Validation |
|
|
| Lean production has become the latest panacea for how manufacturers are to transform themselves into world class operations. Blair McCallum, Head of McKinsey & Company's Production System Design Centre (PSDC) takes a look at the pros and cons, in Making Lean Work - A Holistic Approach Brings Sustainable Benefits |
|
|
| In Containment by Airflow for Highly Potent Materials, Hari Floura, President of Operations for Applied Containment Engineering Inc., outlines the benefits of using isolation technology systems in manufacture |
|
|
| In New Manufacturing Technologies - From Drug Discovery to Final Product, Benjamin Bryant, Global Communications Lead at Honeywell Industry Solutions for Chemicals, Life Sciences and Consumer Goods, explains the value of newer manufacturing technologies |
|
|
|
| Maren Friedrich, Scientist at the R&D Department of GELITA Europe, discusses how the Dissolution Performance of Pharmaceutical Hard Capsule Gelatine Films can be used as an important tool to select the optimised gelatine type and quality for the production of hard gelatine capsules |
|
|
| In Options in Materials for Liquid-Filled Capsules, William Bowtle, Technical Director at MW Encap Ltd, describes the current status of various potential substitutes for gelatine two-piece capsules, with particular reference to their suitability for liquid products |
|
|
| The manufacturing of gelatine capsules is an exacting operation that requires specific conditions to ensure the highest quality of the final product. Ing. Koen Egberts, International Sales Manager for Kathabar Systems, guides us through the processes, in Drying Technology - Soft Capsule Manufacturing |
|
|
| Alan Holmes, Sales Manager at Raupack, addresses the challenges that face the packaging and device industry when developing systems for the new generation of micronised inhaler powder drug delivery systems, in Filling Systems for Inhalant Powders - Trends and Challenges |
|
|
| In Advances in Tabletting, Dr John Fell of the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester, and Consultant to Manesty's Process Development Group, discusses advances in the behaviour of materials during compression, excipients and the impact of regulatory authorities in this area |
|
|
|
| In Developing Custom Adhesive Systems for Transdermal Drug Delivery Products, Melinda Hopp, Director of Marketing at Adhesives Research, Inc., explains how technological advances in adhesives are helping to forge partnerships between adhesives manufacturers and pharmaceutical companies |
|
|
| Daan Crommelin and Gert Bos of OctoPlus and Gert Storm of the Utrecht Institute for Pharmaceutical Sciences, review the use of liposomes in drug delivery, in Liposomes - Successful Carrier Systems for Targeted Drug Delivery |
|
|
| In Liposomes as Drug Delivery Systems, Dr Piotr Slifirski, Head of the Pharmaceutical Department at the Pharmaceutical Research Institute in Poland, outlines the benefits of using liposomes in pharmacy and medicine as carriers of active substances |
|
|
| In recent years, the nasal route has received a great deal of attention as a convenient and reliable method for the systemic administration of several compounds. Pierre Carlotti, Marketing Director at Valois' Pharmaceutical Division, explains why, in Unit-Dose Nasal Sprays - Systemic Delivery Through the Nose |
|
|
|
| Dr Patricia Lobo, Editor of PMPS, speaks to Colleen Ellis, Martin Atkinson and Benjamin Bryant of Honeywell's Automated Control Solutions Division - Chemicals, Life Sciences and Consumer Goods, about the company's activities, in Speeding Time to Market |
|
|
|
| In Nutraceuticals Production Standards, Dr Cesare Dognini, Quality Assurance Manager at Fine Foods NTM S.p.A., investigates the standards that need to be observed in order to maintain quality production |
|
|
|
| In Functional Labels and What they are Used For, Peter Seidl, Sales Manager of Schreiner's MediPharm Business Unit at Schreiner Label and Self-Adhesion Technology, looks at the benefits of labels that are equipped with additional functional features |
|
|
| Developing a containment strategy has become a moving target as the exposure limits for new drug compounds become increasingly low. Henry Rahe, Director of Technology at Containment Technologies Group, Inc., suggests a solution in Containment of Potent Compounds - The New Paradigm |
|
|
| Adrian Simmons, Manager of Security Systems Europe for Westvaco Brand Security, discusses the importance of Shaping a Brand Security Programme at a time when branded global products are at risk from clandestine attack from the illegal trafficking of counterfeit goods |
|
|
| As medical and pharmaceutical science progresses, so must the packaging solutions essential to the task of delivering drugs to the point of use. Stefan Glimm, Secretary General of the European Aluminium Foil Association, endorses the use of Aluminium Foil - A Versatile Tool for Pharmaceutical Packaging |
|
|
| In Pharmaceutical Containers Inspection - Quality Insurance for the Manufacturer, Etienne Botman, Managing Director, and Ludovic Dormal, Sales Engineer at VISIGLAS SA, explore the challenges faced by glass manufacturers working in the pharmaceutical industry |
|
|
| The FDA's June 1999 Container Closure Guidance has accelerated the requirements for extractable and leachable testing of container/closure packaging components. Frances DeGrazio, Vice President of Quality Assurance at West Pharmaceutical Services, Inc., examines The Importance of Leachables and Extractables Testing for a Successful Product Launch |
|
|
|
| Rebecca Cavalфt of PMPS previews CPhI Worldwide 2002, which takes place between 1st and 3rd October 2002 in France, in The CPhI Worldwide 2002 Conference Preview - Where Science Comes First |
|
|
| Dr Patricia Lobo, Editor of PMPS reviews the final Interphex show which took place in Birmingham between 21st and 23rd May, in Interphex 2002 - A Dedicated Pharmaceutical Event |
|
|
|
| The Polish pharmaceutical industry has undergone tremendous change over the past 12 years. Wladyslaw Rzycki, Attorney at White & Case explains how the industry is coping, in The Polish Pharmaceutical Industry - Dynamic Growth in a Challenging Legal Environment |
|
|
| In MES or Mess? - The Creation of Management Information and the Effective Use of Production Data in Pharmaceutical Manufacturing, Espen Gisvold, Managing Director of ESGH, analyses the data and information needs of the various participants in the production, delivery and decision processes |
|
|
| Dolores Birlanga, a Managing Head at Caleidos e-Linguistic Solutions, highlights the importance of translation as a selling point when tackling the worldwide market, in If You Want to be Global, You Need to be Local |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
__________________________
__________________________
__________________________
__________________________
|
